India's Cipla cuts prices of 3 cancer drugs by up to 64 pct Reuters Nov 8 (Reuters) - Indian drugmaker Cipla cut prices of three cancer drugs between 50 percent and 64 percent with immediate effect, after it announced similar price cuts for three drugs early this year. Lung cancer drug Erlocip would cost 9,900 rupees ... |
